Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
It is touted as the first quadruple agonist peptide, designed to simultaneously activate four key hormone receptors involved in metabolism: the insulin-like growth factor 1 receptor (IGF-1R), the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR)
Protective role of butyrate in obesity and diabetes: New insights
Researchers also found that quality of life as measured by DLQI improved in all patients from day 0 to day 56 and patients treated with melanotan I were able to spend up to seven times longer in direct sunlight without experiencing pain [10]
The expanding landscape of GLP-1 medicines
The drug primarily increases insulin secretion and decreases glucagon secretion in a glucose-dependent manner
